Bristol-Myers Squibb Company (BMY) reported revenue of $48.19B and net profit of $7.05B. Revenue grew 1.3% YoY with a net profit margin of 14.6%. The company maintains strong positioning in the Healthcare sector. BUY | PT USD 64.38 (+12.0% upside).
Access the complete analysis, financial model, price target breakdown, and risk factors.
Read Full Report →2 free reads per day · No credit card required